Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study
Evidence suggests that selective serotonin reuptake inhibitors (SSRIs, a class of antidepressant medications) may contribute to increased breast cancer risk by stimulating the secretion of prolactin, a potential tumour promoter. The main objective of this study was to determine breast cancer risk as...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en en |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1974/971 |